Optics.org | February 13, 2019: Researchers are using near-infrared light to kill off cancer cells while also creating immunotherapy to guard against any future cancer relapse and distant metastasis.
That message was the core of a keynote speech at Photonics West in San Francisco, last week, for an imaging and therapy session by Hisataka Kobayashi, chief scientist and senior investigator at the Molecular Imaging Program in the U.S. National Cancer Institute’s Center for Cancer Research in Bethesda, Maryland.
